Our research organization, The Institute for Quality Resource Management, has a proven track record in helping manufacturers plan, design protocols, enroll patients, and direct clinical trials for new medical products. We have devised a method to collect relevant cost and outcome data during the process of your clinical trial. This process, if undertaken concurrently with Phase III clinical trials, can enhance your product’s time to market with improved financial success. Data gathered during the clinical trial phase can help derive our cost effectiveness formulas.